These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 28648777)

  • 1. mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT.
    Gu Y; Albuquerque CP; Braas D; Zhang W; Villa GR; Bi J; Ikegami S; Masui K; Gini B; Yang H; Gahman TC; Shiau AK; Cloughesy TF; Christofk HR; Zhou H; Guan KL; Mischel PS
    Mol Cell; 2017 Jul; 67(1):128-138.e7. PubMed ID: 28648777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.
    Shin CS; Mishra P; Watrous JD; Carelli V; D'Aurelio M; Jain M; Chan DC
    Nat Commun; 2017 Apr; 8():15074. PubMed ID: 28429737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment.
    Masui K; Cavenee WK; Mischel PS
    Brain Pathol; 2015 Nov; 25(6):755-9. PubMed ID: 26526943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy.
    Qian X; Li X; Cai Q; Zhang C; Yu Q; Jiang Y; Lee JH; Hawke D; Wang Y; Xia Y; Zheng Y; Jiang BH; Liu DX; Jiang T; Lu Z
    Mol Cell; 2017 Mar; 65(5):917-931.e6. PubMed ID: 28238651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
    Lien EC; Ghisolfi L; Geck RC; Asara JM; Toker A
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).
    Yamaguchi I; Yoshimura SH; Katoh H
    J Biol Chem; 2020 May; 295(20):6936-6945. PubMed ID: 32265299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling.
    Masui K; Shibata N; Cavenee WK; Mischel PS
    Bioessays; 2016 Sep; 38(9):839-44. PubMed ID: 27427440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IKK interacts with rictor and regulates mTORC2.
    Xu Y; Lai E; Liu J; Lin J; Yang C; Jia C; Li Y; Bai X; Li M
    Cell Signal; 2013 Nov; 25(11):2239-45. PubMed ID: 23872070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of mTOR in glioblastoma.
    Duzgun Z; Eroglu Z; Biray Avci C
    Gene; 2016 Jan; 575(2 Pt 1):187-90. PubMed ID: 26341051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.
    Masui K; Tanaka K; Akhavan D; Babic I; Gini B; Matsutani T; Iwanami A; Liu F; Villa GR; Gu Y; Campos C; Zhu S; Yang H; Yong WH; Cloughesy TF; Mellinghoff IK; Cavenee WK; Shaw RJ; Mischel PS
    Cell Metab; 2013 Nov; 18(5):726-39. PubMed ID: 24140020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
    Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY
    Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex.
    Liu P; Gan W; Chin YR; Ogura K; Guo J; Zhang J; Wang B; Blenis J; Cantley LC; Toker A; Su B; Wei W
    Cancer Discov; 2015 Nov; 5(11):1194-209. PubMed ID: 26293922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.
    Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y
    Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC2 phosphorylates protein kinase Cζ to regulate its stability and activity.
    Li X; Gao T
    EMBO Rep; 2014 Feb; 15(2):191-8. PubMed ID: 24375676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
    Chen L; Li X; Liu L; Yu B; Xue Y; Liu Y
    Oncol Rep; 2015 Mar; 33(3):1465-74. PubMed ID: 25585997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.
    Teramoto K; Katoh H
    Cell Signal; 2019 Oct; 62():109329. PubMed ID: 31152846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.
    Koppula P; Zhang Y; Zhuang L; Gan B
    Cancer Commun (Lond); 2018 Apr; 38(1):12. PubMed ID: 29764521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1.
    Moloughney JG; Kim PK; Vega-Cotto NM; Wu CC; Zhang S; Adlam M; Lynch T; Chou PC; Rabinowitz JD; Werlen G; Jacinto E
    Mol Cell; 2016 Sep; 63(5):811-26. PubMed ID: 27570073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.